BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/30/2022 10:58:50 PM | Browse: 152 | Download: 144
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
|
Manuscript Source |
Invited Manuscript |
All Author List |
Arata Nishimoto |
Funding Agency and Grant Number |
|
Corresponding Author |
Arata Nishimoto, PhD, Professor, Division of Basic Pharmaceutical Science, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori
, Sanyo-Onoda City 756-0884, Yamaguchi, Japan. anishimo@rs.socu.ac.jp |
Key Words |
Pancreatic cancer; Gemcitabine; Targeted drug; Combination therapy |
Core Tip |
Gemcitabine has been the standard chemotherapy drug for patients with pancreatic cancer; however, its effectiveness is limited. Therefore, various combination therapies involving gemcitabine and targeted drugs are being explored. A review of combination therapies based mainly on clinical studies has been published recently; therefore, this minireview focuses on the findings of basic studies and discusses combinations of gemcitabine and targeted drugs, combinations of targeted drugs, combinations of natural products and anti-cancer agents, including gemcitabine, and combinations among natural products. |
Citation |
Nishimoto A. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World J Gastroenterol 2022; 28(28): 3637-3643 |
|
Received |
|
2022-04-01 08:39 |
|
Peer-Review Started |
|
2022-04-01 08:41 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-09 06:34 |
|
Revised |
|
2022-06-06 03:12 |
|
Second Decision |
|
2022-06-29 03:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-06-30 22:58 |
|
Articles in Press |
|
2022-06-30 22:58 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-01 06:09 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345